William R Lenderking
Biographic Data
| ID | 5546038 |
|---|---|
| NAME | William R Lenderking |
| GIVEN NAMES | William R |
| FAMILY NAME | Lenderking |
| SIGNATURE | LENDERKING W R |
| AFFILIATIONS | Pfizer (United States) |
| VERIFIED | No |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 10 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1997 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies
Assessment of Parkinson’s disease levodopa-induced dyskinesia
Isoqol recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
Is Rasch model analysis applicable in small sample size pilot studies for assessing item characteristics? An example using PROMIS pain behavior item bank data
The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research
BACKGROUND: The goal of comparative effectiveness research (CER) is to explain the differential benefits and harms of alternate methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. To inform decision making, information from the patient's perspective that reflects outcomes that patients care about are needed and can be collected rigorously using appropriate patient-reported outcomes (PRO). It c…
US and UK versions of the EQ-5D preference weights
A Brief Mental Health Outcomes Measure
The Psychology of Quality of Life
Summary and recommendations for future research
Measuring quality of life in early HIV disease
No prominent works on this page.
Summary and recommendations for future research
Measuring quality of life in early HIV disease
The Psychology of Quality of Life
A Brief Mental Health Outcomes Measure
US and UK versions of the EQ-5D preference weights
The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research
BACKGROUND: The goal of comparative effectiveness research (CER) is to explain the differential benefits and harms of alternate methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. To inform decision making, information from the patient's perspective that reflects outcomes that patients care about are needed and can be collected rigorously using appropriate patient-reported outcomes (PRO). It c…
Isoqol recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
Is Rasch model analysis applicable in small sample size pilot studies for assessing item characteristics? An example using PROMIS pain behavior item bank data
International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies
Assessment of Parkinson’s disease levodopa-induced dyskinesia
Medicine (8 works) · Psychology (6 works) · Public health (6 works) · Quality of Life Research (5 works) · Psychometrics (4 works) · Quality of life (healthcare (4 works) · Clinical Psychology (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Internal Medicine (3 works) · Nursing (3 works)